{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:23:19Z","timestamp":1792801399463,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.biopha.2013.09.001","type":"journal-article","created":{"date-parts":[[2013,10,8]],"date-time":"2013-10-08T04:00:26Z","timestamp":1381204826000},"page":"101-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"title":["Protective mechanisms of atorvastatin against doxorubicin-induced hepato-renal toxicity"],"prefix":"10.1016","volume":"68","author":[{"given":"Mohamed A.","family":"El-Moselhy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azza A.K.","family":"El-Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2013.09.001_bib0005","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S1734-1140(09)70018-0","article-title":"Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron","volume":"61","author":"Sim\u016fnek","year":"2009","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.biopha.2013.09.001_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v25.i1.10","article-title":"Engineered nanocarriers of doxorubicin: a current update","volume":"25","author":"Patil","year":"2008","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"10.1016\/j.biopha.2013.09.001_bib0015","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/mutage\/ges079","article-title":"Effect of dihydrokainate on the capacity of repair of DNA damage and apoptosis induced by doxorubicin","volume":"28","author":"Attia","year":"2013","journal-title":"Mutagenesis"},{"key":"10.1016\/j.biopha.2013.09.001_bib0020","article-title":"The protective effects of omega-3 fatty acids on doxorubicin-induced hepatotoxicity and nephrotoxicity in rats","author":"Tulubas","year":"2013","journal-title":"Toxicol Ind Health"},{"key":"10.1016\/j.biopha.2013.09.001_bib0025","first-page":"981461","article-title":"Effect of coenzyme-q10 on Doxorubicin-induced nephrotoxicity in rats","volume":"2012","author":"El-Sheikh","year":"2012","journal-title":"Adv Pharmacol Sci"},{"key":"10.1016\/j.biopha.2013.09.001_bib0030","doi-asserted-by":"crossref","first-page":"681367","DOI":"10.1155\/2012\/681367","article-title":"The redox imbalance and the reduction of contractile protein content in rat hearts administered with L-thyroxine and Doxorubicin","volume":"2012","author":"Korga","year":"2012","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.biopha.2013.09.001_bib0035","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.bbrc.2012.04.150","article-title":"ARD1 binding to RIP1 mediates doxorubicin-induced NF-kappaB activation","volume":"422","author":"Park","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.biopha.2013.09.001_bib0040","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00005-009-0051-8","article-title":"Cardiomyocyte death in doxorubicin-induced cardiotoxicity","volume":"57","author":"Zhang","year":"2009","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.biopha.2013.09.001_bib0045","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.yjmcc.2006.11.016","article-title":"Acute doxorubicin cardiotoxicity is successfully treated with the phytochemical oleuropein through suppression of oxidative and nitrosative stress","volume":"42","author":"Andreadou","year":"2007","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.biopha.2013.09.001_bib0050","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1016\/j.biomaterials.2008.04.048","article-title":"Potential hepato-protective effects of fullerenol C60(OH)24 in doxorubicin-induced hepatotoxicity in rats with mammary carcinomas","volume":"29","author":"Injac","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2013.09.001_bib0055","doi-asserted-by":"crossref","first-page":"390238","DOI":"10.1155\/2011\/390238","article-title":"Doxorubicin induced nephrotoxicity: protective effect of nicotinamide","volume":"2011","author":"Ayla","year":"2011","journal-title":"Int J Cell Biol"},{"key":"10.1016\/j.biopha.2013.09.001_bib0060","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1517\/14740338.2010.495385","article-title":"Atorvastatin: safety and tolerability","volume":"9","author":"Athyros","year":"2010","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.biopha.2013.09.001_bib0065","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.yjmcc.2009.07.024","article-title":"Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity","volume":"47","author":"Yoshida","year":"2009","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.biopha.2013.09.001_bib0070","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3109\/15376516.2012.678406","article-title":"Cardioprotective effects of rosuvastatin and carvedilol on delayed cardiotoxicity of doxorubicin in rats","volume":"22","author":"Kim","year":"2012","journal-title":"Toxicol Mech Methods"},{"key":"10.1016\/j.biopha.2013.09.001_bib0075","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1016\/j.jacc.2012.07.067","article-title":"Effect of statin therapy on the risk for incident heart failure in patients with breast cancer receiving anthracycline chemotherapy: an observational clinical cohort study","volume":"60","author":"Seicean","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.biopha.2013.09.001_bib0080","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/S0002-9149(02)02355-X","article-title":"The liver and lovastatin","volume":"89","author":"Tolman","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.biopha.2013.09.001_bib0085","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.taap.2012.03.012","article-title":"The lipid lowering drug lovastatin protects against doxorubicin-induced hepatotoxicity","volume":"261","author":"Henninger","year":"2012","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.biopha.2013.09.001_bib0090","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/sj.ki.5002674","article-title":"Angiotensin converting enzyme inhibitor but not angiotensin receptor blockade or statin ameliorates murine adriamycin nephropathy","volume":"73","author":"Tang","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.biopha.2013.09.001_bib0095","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1007\/s00467-008-0933-8","article-title":"Simvastatin ameliorates glomerulosclerosis in Adriamycin-induced-nephropathy rats","volume":"23","author":"Zhang","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.biopha.2013.09.001_bib0100","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1080\/08860220902835863","article-title":"Atorvastatin prevents gentamicin-induced renal damage in rats through the inhibition of p38-MAPK and NF-kappaB pathways","volume":"31","author":"Ozbek","year":"2009","journal-title":"Ren Fail"},{"key":"10.1016\/j.biopha.2013.09.001_bib0105","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0076-6879(78)52032-6","article-title":"Microsomal lipid peroxidation","volume":"52","author":"Buege","year":"1978","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.biopha.2013.09.001_bib0110","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/abio.2002.5676","article-title":"Spectrophotometric determination of serum nitrite and nitrate by copper-cadmium alloy","volume":"306","author":"Sastry","year":"2002","journal-title":"Anal Biochem"},{"key":"10.1016\/j.biopha.2013.09.001_bib0115","series-title":"Theory and practice of histological techniques","author":"Bancroft","year":"2008"},{"key":"10.1016\/j.biopha.2013.09.001_bib0120","first-page":"CD008226","article-title":"Lipid lowering efficacy of atorvastatin","volume":"12","author":"Adams","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.biopha.2013.09.001_bib0125","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s13105-013-0240-0","article-title":"Protective role of atorvastatin against doxorubicin-induced cardiotoxicity and testicular toxicity in mice","volume":"69","author":"Svvs","year":"2013","journal-title":"J Physiol Biochem"},{"key":"10.1016\/j.biopha.2013.09.001_bib0130","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.jacc.2011.05.025","article-title":"Efficiency of atorvastatin in the protection of anthracycline-induced cardiomyopathy","volume":"58","author":"Acar","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.biopha.2013.09.001_bib0135","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/ijc.24885","article-title":"Double impact on p-glycoprotein by statins enhances doxorubicin cytotoxicity in human neuroblastoma cells","volume":"126","author":"Sieczkowski","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.biopha.2013.09.001_bib0140","first-page":"291","article-title":"Antitumor and apoptosis promoting properties of atorvastatin, an inhibitor of HMG-CoA reductase, against Dalton's Lymphoma Ascites tumor in mice","volume":"7","author":"Ajith","year":"2008","journal-title":"J Exp Ther Oncol"},{"key":"10.1016\/j.biopha.2013.09.001_bib0145","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000339472","article-title":"Beneficial effects of high-dose atorvastatin pretreatment on renal function in patients with acute ST-segment elevation myocardial infarction undergoing emergency percutaneous coronary intervention","volume":"122","author":"Li","year":"2012","journal-title":"Cardiology"},{"key":"10.1016\/j.biopha.2013.09.001_bib0150","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/HCR.0b013e318255a382","article-title":"Cardiac rehabilitation participant with sickle cell trait and statin-related hepatotoxicity: a case report","volume":"32","author":"Kato","year":"2012","journal-title":"J Cardiopulm Rehabil Prev"},{"key":"10.1016\/j.biopha.2013.09.001_bib0155","first-page":"417","article-title":"Effects of different statin regimens on lipid profile and serum metalloproteinases in patients with coronary heart disease","volume":"37","author":"Liang","year":"2009","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"10.1016\/j.biopha.2013.09.001_bib0160","first-page":"254","article-title":"Oxidative markers, nitric oxide and homocysteine alteration in hypercholesterolimic rats: role of atorvastatine and cinnamon","volume":"2","author":"Amin","year":"2009","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.biopha.2013.09.001_bib0165","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.phymed.2010.04.007","article-title":"Effect of combined administration of ginger (Zingiber officinale Roscoe) and atorvastatin on the liver of rats","volume":"17","author":"Heeba","year":"2010","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2013.09.001_bib0170","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jhep.2010.08.031","article-title":"Targeting cholesterol at different levels in the mevalonate pathway protects fatty liver against ischemia-reperfusion injury","volume":"54","author":"Llacuna","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.biopha.2013.09.001_bib0175","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00280-004-0833-y","article-title":"Redox-cycling of anthracyclines by thioredoxin system: increased superoxide generation and DNA damage","volume":"54","author":"Ravi","year":"2004","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.biopha.2013.09.001_bib0180","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1124\/jpet.110.170191","article-title":"Long-acting phosphodiesterase-5 inhibitor tadalafil attenuates doxorubicin-induced cardiomyopathy without interfering with chemotherapeutic effect","volume":"334","author":"Koka","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.biopha.2013.09.001_bib0185","first-page":"2697","article-title":"Protective effects of silymarin against doxorubicin-induced toxicity","volume":"12","author":"Cecen","year":"2011","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.biopha.2013.09.001_bib0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbt.20422","article-title":"The protective effect of aminoguanidine on doxorubicin-induced nephropathy in rats","volume":"26","author":"Abo-Salem","year":"2012","journal-title":"J Biochem Mol Toxicol"},{"key":"10.1016\/j.biopha.2013.09.001_bib0195","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10238-011-0165-2","article-title":"Catechin protects against oxidative stress and inflammatory-mediated cardiotoxicity in adriamycin-treated rats","volume":"12","author":"Abd El-Aziz","year":"2012","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.biopha.2013.09.001_bib0200","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0306-3623(98)00179-7","article-title":"Anticancer drugs inhibit induction of NO synthase in rat in vivo","volume":"32","author":"Inagaki","year":"1999","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.biopha.2013.09.001_bib0205","doi-asserted-by":"crossref","first-page":"11293","DOI":"10.1021\/bi971475e","article-title":"Endothelial nitric oxide synthase-dependent superoxide generation from adriamycin","volume":"36","author":"V\u00e1squez-Vivar","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.biopha.2013.09.001_bib0210","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.niox.2012.03.006","article-title":"Dietary inorganic nitrate alleviates doxorubicin cardiotoxicity: mechanisms and implications","volume":"26","author":"Xi","year":"2012","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.biopha.2013.09.001_bib0215","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1021\/mp300311b","article-title":"Mitochondrial-targeting nitrooxy-doxorubicin: a new approach to overcome drug resistance","volume":"10","author":"Riganti","year":"2013","journal-title":"Mol Pharm"},{"key":"10.1016\/j.biopha.2013.09.001_bib0220","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1097\/HJH.0b013e32833e0924","article-title":"Atorvastatin upregulates nitric oxide synthases with Rho-kinase inhibition and Akt activation in the kidney of spontaneously hypertensive rats","volume":"28","author":"Ito","year":"2010","journal-title":"J Hypertens"},{"key":"10.1016\/j.biopha.2013.09.001_bib0225","doi-asserted-by":"crossref","first-page":"F263","DOI":"10.1152\/ajprenal.00109.2010","article-title":"Statins reverse renal inflammation and endothelial dysfunction induced by chronic high salt intake","volume":"301","author":"Fiore","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.biopha.2013.09.001_bib0230","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.2042-7158.2011.01285.x","article-title":"Suppression of inflammatory response and endothelial nitric oxide synthase downregulation in hyperlipidaemic C57BL\/6J mice by eugenosedin-A","volume":"63","author":"Shen","year":"2011","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.biopha.2013.09.001_bib0235","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1440-1746.2012.07123.x","article-title":"Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation","volume":"27","author":"Ajamieh","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.biopha.2013.09.001_bib0240","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1191\/1358863x03vm476oa","article-title":"Rapid-onset endothelial dysfunction with adriamycin: evidence for a dysfunctional nitric oxide synthase","volume":"8","author":"Duquaine","year":"2003","journal-title":"Vasc Med"},{"key":"10.1016\/j.biopha.2013.09.001_bib0245","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1161\/01.CIR.0000048192.52098.DD","article-title":"Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction","volume":"107","author":"Pacher","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2013.09.001_bib0250","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00210-009-0407-y","article-title":"Differential roles of nitric oxide synthase isozymes in cardiotoxicity and mortality following chronic doxorubicin treatment in mice","volume":"380","author":"Deng","year":"2009","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.biopha.2013.09.001_bib0255","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.taap.2010.11.011","article-title":"Reduction of liver fructokinase expression and improved hepatic inflammation and metabolism in liquid fructose-fed rats after atorvastatin treatment","volume":"251","author":"Vil\u00e0","year":"2011","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.biopha.2013.09.001_bib0260","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1172\/JCI28570.","article-title":"TNF-alpha downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents","volume":"116","author":"Valerio","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.biopha.2013.09.001_bib0265","doi-asserted-by":"crossref","first-page":"e518","DOI":"10.1038\/cddis.2013.44","article-title":"HMG-CoA reductase inhibitors induce apoptosis of lymphoma cells by promoting ROS generation and regulating Akt, Erk and p38 signals via suppression of mevalonate pathway","volume":"4","author":"Qi","year":"2013","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.biopha.2013.09.001_bib0270","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.3892\/or.2013.2301","article-title":"Promising anti-leukemic activity of atorvastatin","volume":"9","author":"Zolnierczyk","year":"2013","journal-title":"Oncol Rep"},{"key":"10.1016\/j.biopha.2013.09.001_bib0275","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.vph.2010.10.001","article-title":"Does atorvastatin induce aortic smooth muscle cell apoptosis in vivo?","volume":"54","author":"Doyon","year":"2011","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.biopha.2013.09.001_bib0280","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/abbs\/gmr087","article-title":"Efficacy of Atorvastatin combined with adipose-derived mesenchymal stem cell transplantation on cardiac function in rats with acute myocardial infarction","volume":"43","author":"Cai","year":"2011","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"10.1016\/j.biopha.2013.09.001_bib0285","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1006\/abbi.1997.0340","article-title":"Comparison of oxygen radical generation from the reductive activation of doxorubicin, streptonigrin, and menadione by xanthine oxidase and xanthine dehydrogenase","volume":"347","author":"Yee","year":"1997","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.biopha.2013.09.001_bib0290","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1089\/ars.2007.1632","article-title":"Mitochondrial and nuclear p53 localization in cardiomyocytes: redox modulation by doxorubicin (Adriamycin)?","volume":"9","author":"Nithipongvanitch","year":"2007","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.biopha.2013.09.001_bib0295","doi-asserted-by":"crossref","first-page":"606183","DOI":"10.1155\/2012\/606183","article-title":"Different effects of resveratrol on dose-related Doxorubicin-induced heart and liver toxicity","volume":"2012","author":"Dudka","year":"2012","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.biopha.2013.09.001_bib0300","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1152\/ajpgi.00001.2006","article-title":"Mechanisms of liver injury. III. Role of glutathione redox status in liver injury","volume":"291","author":"Han","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.biopha.2013.09.001_bib0305","doi-asserted-by":"crossref","first-page":"8398","DOI":"10.1158\/1078-0432.CCR-05-0885","article-title":"The nuclear transcription factor kappaB\/bcl-2 pathway correlates with pathologic complete response to doxorubicin-based neoadjuvant chemotherapy in human breast cancer","volume":"11","author":"Buchholz","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.biopha.2013.09.001_bib0310","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1089\/ars.2009.2611","article-title":"Redox regulation of tumor necrosis factor signaling","volume":"11","author":"Han","year":"2009","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.biopha.2013.09.001_bib0315","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/eci.12092","article-title":"Lectin-like oxidized low-density lipoprotein receptor 1 pathways","volume":"43","author":"Taye","year":"2013","journal-title":"Eur J Clin Invest"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332213001078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332213001078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:53:38Z","timestamp":1760093618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332213001078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0753332213001078"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2013.09.001","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective mechanisms of atorvastatin against doxorubicin-induced hepato-renal toxicity","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2013.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}